Core Viewpoint - AxoGen (AXGN) shares have increased by 16.6% in the past four weeks, closing at $14.01, with a mean price target of $24.71 indicating a potential upside of 76.4% [1] Price Targets and Analyst Estimates - The mean estimate consists of seven short-term price targets with a standard deviation of $3.2, where the lowest estimate of $20.00 suggests a 42.8% increase, and the highest estimate of $30.00 indicates a 114.1% increase [2] - A low standard deviation signifies strong agreement among analysts regarding the stock's price movement, which can be a useful starting point for further research [9] Earnings Estimates and Analyst Optimism - Analysts show strong agreement in revising earnings per share (EPS) estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, two estimates have been revised upward, leading to a 27.1% increase in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - AXGN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] - While consensus price targets may not be entirely reliable, the implied direction of price movement appears to be a good guide for potential investment [14]
Wall Street Analysts Predict a 76.37% Upside in AxoGen (AXGN): Here's What You Should Know